Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exploring autoantigens in autoimmune limbic encephalitis using phage immunoprecipitation sequencing

Journal of Neurology(2025)10.1007/s00415-025-13039-7Source: DataRank Database

Exploring autoantigens in autoimmune limbic encephalitis using phage immunoprecipitation sequencing is a research paper published in Journal of Neurology (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.19)OA: greenTopics (63)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Naveen Kumar Paramasivan ORCID,Surendra Dasari ORCID,Carley Karsten,Smathorn Thakolwiboon ORCID,Michael Gilligan ORCID

Live enrichment

PubMed:40133514 PMC:PMC12476888 OpenAlex:https://openalex.org/W4408885146

NINDS NIH HHS

Grant: R01 NS126227

NINDS NIH HHS

Grant: U01 NS120901

National Institutes of Health

Grant: 5R01NS126227-04

Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping

National Institutes of Health

Grant: 3U01NS120901-04S1

A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease

FWCI

4.19

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12476888/pdf/nihms-2110824.pdf

GREENhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12476888/pdf/nihms-2110824.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12476888/pdf/nihms-2110824.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00415-025-13039-7.pdf

publisherhttps://link.springer.com/article/10.1007/s00415-025-13039-7/fulltext.html

Fields of Study

Autoimmune Neurological Disorders and TreatmentsMultiple Sclerosis Research StudiesOtitis Media and Relapsing PolychondritisMedicineBiology03 medical and health sciences0302 clinical medicineHumansAutoantigensLimbic EncephalitisFemaleMaleMiddle AgedAutoimmune DiseasesAgedAutoantibodiesImmunoprecipitationAdultBasic Helix-Loop-Helix ProteinsCOVID-19Autoimmune limbic encephalitis

MeSH Terms

COVID-19AdultAgedAutoantibodiesAutoantigensAutoimmune DiseasesFemaleHumansMaleMiddle AgedNerve Tissue ProteinsLimbic EncephalitisImmunoprecipitationBasic Helix-Loop-Helix Transcription FactorsBasic Helix-Loop-Helix Proteins

Keywords

Limbic encephalitisAutoantibodyAutoimmune encephalitisMedicineImmunologyAntibodyCerebrospinal fluidEncephalitisPathologyVirusCognitive DysfunctionAdenylate Kinase 5 (Ak5)Phage Immunoprecipitation Sequencing (Phip-seq)Neuronal Pas Domain Protein 4 (Npas4)MaleAdultBasic Helix-Loop-Helix ProteinsCOVID-19Middle AgedAutoantigensArticleAutoimmune DiseasesHumansImmunoprecipitationFemaleAgedAutoantibodies

Sustainable Development Goals

SDG 0: Good health and well-being